| |
| |
|
| Insider
Information: |
Korbel Gregory Alan |
| Relationship: |
SVP, Chief Operating O... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
45,762 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,762 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aprea Therapeutics, Inc. |
APRE |
SVP, Chief Operating O... |
2022-07-28 |
45,762 |
2019-10-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Operating Officer |
• – – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,300 |
45,762 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Operating Officer |
• • – |
2022-06-03 |
4 |
D |
$0.81 |
$6,754 |
D/D |
(8,390) |
21,462 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• • – |
2022-03-10 |
4 |
D |
$1.82 |
$3,620 |
D/D |
(1,989) |
29,852 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
31,841 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2022-02-25 |
4 |
D |
$1.74 |
$2,307 |
D/D |
(1,326) |
15,841 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-12-01 |
4 |
AS |
$3.96 |
$108,900 |
D/D |
(27,500) |
17,167 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-12-01 |
4 |
OE |
$0.92 |
$25,300 |
D/D |
27,500 |
44,667 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-11-01 |
4 |
AS |
$5.00 |
$137,500 |
D/D |
(27,500) |
17,167 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-11-01 |
4 |
OE |
$0.92 |
$25,300 |
D/D |
27,500 |
44,667 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-10-01 |
4 |
AS |
$4.89 |
$134,475 |
D/D |
(27,500) |
17,167 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-10-01 |
4 |
OE |
$0.92 |
$25,300 |
D/D |
27,500 |
44,667 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-09-20 |
4 |
AS |
$4.97 |
$163,866 |
D/D |
(32,960) |
17,167 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Business Officer |
• – – |
2021-09-20 |
4 |
OE |
$0.92 |
$25,300 |
D/D |
27,500 |
44,667 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-09-10 |
4 |
D |
$4.59 |
$7,913 |
D/D |
(1,724) |
22,627 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-08-25 |
4 |
D |
$3.98 |
$4,573 |
D/D |
(1,149) |
24,351 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Chief Business Officer |
• • – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
25,500 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
VP of Business Devt |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,500 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
VP of Business Devt |
• • – |
2019-10-07 |
4 |
B |
$15.00 |
$7,500 |
D/D |
500 |
500 |
0.01 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
